Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pharmacokinetic and Bioavailability Studies of PHN131, an Oral Formulation of Nalbuphine Hydrochloride, in Healthy Volunteers

NCT02192151 is registered in ClinicalTrials.gov with PhytoHealth Corporation as lead sponsor.

NCT NCT02192151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02192151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pharmacokinetic and Bioavailability Studies of PHN131, an Oral Formulation of Nalbuphine Hydrochloride, in Healthy Volunteers
Lead sponsor
PhytoHealth Corporation
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
October 31, 2012
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia disorder